Vázquez F, Lavielle P, Gómez-Díaz R, Wacher N

Language: Spanish
References: 29
Page: 156-161
PDF size: 204.49 Kb.

ABSTRACT

Introduction: Refusal of physicians to prescribe insulin to their patients has been scarcely evaluated; the delay in treatment intensification hinders adequate and quality care. Objective: To identify the perception of primary care physicians about barriers to initiate insulin treatment in patients with diabetes. Method: Using the Smith Index and multivariate analysis, the relevance and grouping of concepts related to barriers to insulin prescription were assessed in 81 family doctors. Results: Only 35.8% of physicians showed confidence for prescribing insulin; almost half of them rated treatment intensification between moderately and little important (39.5% and 6.2%). Barriers were related to the physician (39.5%), the patient (37%), insulin treatment (11.1%) and the institution (6.2%); 6.2 % of physicians did not perceive any barrier. The barriers were grouped in 5 factors that explained 62.48% of the variance: patient cultural level, lack of medical skills, fear of adverse events, insecurity and lack of training. Conclusion: Clinical inertia was not the result of a complex medical condition or patient comorbidities, but of doctor’s perception and confidence in his/her clinical and communication skills.

REFERENCES

1. World Health Organization. Global status report on non-communicable diseases. Ginebra, Suiza: World Health Organization; 2014.

2. International Diabetes Federation. DF Diabetes Atlas. Octava edición. Bélgica: International Diabetes Federation; 2018.

3. Hernández-Ávila M, Rivera-Dommarco J, Shamah-Levy T, Cuevas-Nasu L, Gómez-Acosta LM, Gaona-Pineda EB, et al. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Informe final de resultados. México: Secretaría de Salud/Instituto Nacional de Salud Pública; 2016.

4. Hernández-Ávila M, Gutiérrez JP, Reynoso-Noverón N. Diabetes mellitus in Mexico. Status of the epidemic. Salud Publica Mex. 2013;55:S129-S136.

5. Barag SH. Insulin therapy for management of type 2 diabetes mellitus: strategies for initiation and long-term patient adherence. J Am Osteopath Assoc. 2011;111:S13-S19.

6. Brath H, Paldánius P, Bader G, Kolaczynski WM, Nilsson P. Differences in glycemic control across world regions: a post-hoc analysis in patients with type 2 diabetes mellitus on dual antidiabetes drug therapy. Nutr Diabetes. 2016;6:e217.

7. Hermanns N, Mahr M, Kulzer B, Skovlund SE, Haak T. Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal study. Health Qual Life Outcomes. 2010;8:113.

8. Ali A, Cheng AYY, Yu CH. Breaking down barriers to initiating insulin. Insulin prescription pad. Can Fam Physician. 2015;61:446-447.

9. Brown JB, Nichols GA, Perry A. The burden of treatment failure in type 2 diabetes. Diabetes Care. 2004;27:1535-1540.

10. Khunti K, Wolden ML, Thorsted BL, Andersen M, Davies MJ. Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people. Diabetes Care. 2013;36:3411-3417.

11. Harris SB, Kapor J, Lank CN, Willian AR, Houston T. Clinical inertia in patients with T2DM requiring insulin in family practice. Can Fam Physician. 2010;56:e418-e424.

12. O’Connor PJ. Improving diabetes care by combating clinical inertia. Health Serv Res. 2005;40:1854-1861.

13. Willms D, Johnson N. Essentials in qualitative research: a notebook for the field. Canada: McMaster University; 1996.

14. Krippendorff K. Content analysis: an introduction to its methodology. EE. UU.: Sage Publications Beverly Hills; 1980.

15. Smith JJ, Borgatti SP. Salience counts – and so does accuracy: correcting and updating a measure for free-list-item salience. J Linguistic Anthropol. 1998;7:208-209.

16. Thompson EC, Juan Z. Comparative cultural salience: measures using free-list data. Field Methods. 2006;18:398-412.

17. Romney AK, Weller SC, Batchelder WH. Culture as consensus: a theory of cultural and informant accuracy. Am Anthropol. 1986;88:313-338.

18. DeVellis RF. Scale development. Theory and applications. EE. UU.: Sage Publications; 1991.

19. Nunnally JC. Psychometric theory. EE. UU.: McGraw-Hill; 1978.

20. O’Connor PJ, Sperl-Hillen JA, Johnson PE, Rush WA, Biltz G. Clinical inertia and outpatient medical errors. En: Henriksen K, Battles J, Marks E, Lewin D, editores. Advances in patient safety: from research to implementation. EE. UU.: Agency for Healthcare Research and Quality; 2005.

21. Ratanawongsa N, Crosson JC, Schillinger D, Karter AJ, Saha CK, Marrero DG. Getting under the skin of clinical inertia in insulin initiation: the Translating Research Into Action for Diabetes (TRIAD) Insulin Starts Project. Diabetes Educ. 2012;38 94-100.

22. Escalada J, Orozco-Beltran D, Morillas C, Alvarez-Guisasola F, Gomez- Peralta F, Mata-Cases M, et al. Attitudes towards insulin initiation in type 2 diabetes patients among healthcare providers: a survey research. Diabetes Res Clin Pract. 2016;122:46-53.

23. García-Morales G, Reyes-Jiménez M. Inercia clínica en pacientes con diabetes mellitus tipo 2 en una unidad de medicina familiar de Acapulco, Guerrero, México. Aten Fam. 2017;24:102-106.

24. Lerman I. Barreras que dificultan la aplicación temprana de insulina en el paciente con diabetes tipo 2. ALAD. 2009;17:66-68.

25. Alkhaifi M, Al Khusaibi GA, Theodorson T, Ward MA, Mazrou’I AA. Barriers in initiating insulin treatment in type 2 diabetes mellitus among physicians in Wilayat of Bowsher in Oman. J Fam Med Community Health. 2015;2:1034.

26. Gherman A, Veresiu IA, Sassu RA, Schnur JB, Scheckner BL, Montgomery GH. Psychological insulin resistance: a critical review of the literature. Diabetes Int. 2011;28:125-128.

27. Lee Y, Lee P, Ng CJ. A qualitative study on healthcare professionals’ perceived barriers to insulin initiation in a multi-ethnic population. BMC Fam Pract. 2012;13 28.

28. Owens D. Clinical evidence for the earlier initiation of insulin therapy in type 2 diabetes. Diabetes Technol Ther. 2013;15:776-785.

29. The NHS Atlas of Variation in Healthcare. Reducing unwarranted variation to increase value and improve quality. Inglaterra: Public Health England/NHS Englad/Care Quality Commission/Health and Social Care Information Centre/Office for National Statistics/NHS Improving Quality; 2016.